| Literature DB >> 30819347 |
Nicole Harter1, Anthony J Mancini2.
Abstract
Infantile hemangiomas (IH) are a common benign tumor of infancy, most being uncomplicated and not requiring therapy. Some IH may require treatment; the pediatric provider must be familiar with morphology, distribution, natural history, and associations of IH. Several treatment options are available for IH: current standard of care, oral propranolol. Other therapies include wound care; topical beta-blocker therapy for small, superficial, and uncomplicated IH; treatment of IH residua. In addition to functional compromise and other complications, potential for permanent deformity and eventual psychosocial stigmatization are important when considering the need for treatment of IH in a neonate or infant.Entities:
Keywords: Infantile hemangioma; Neonate; PHACE; Propranolol; Timolol
Mesh:
Substances:
Year: 2019 PMID: 30819347 DOI: 10.1016/j.pcl.2018.12.011
Source DB: PubMed Journal: Pediatr Clin North Am ISSN: 0031-3955 Impact factor: 3.278